Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Jul 17, 2014

Cepheid Reports 2014 Second Quarter Results

Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth
Jul 3, 2014

Cepheid Schedules 2014 Second Quarter Results Announcement And Webcast
Jun 19, 2014

Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections

Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK
Jun 16, 2014

Cepheid Announces European Release of Xpert Carba-R, a Molecular Test for Rapid and Accurate Detection of Carbapenemase-producing Gram-negative Bacteria

On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1
Jun 9, 2014

Cepheid Welcomes Executive Vice President Of International Commercial Operations

Show per page

Back to Top